Hope Through Clinical Research

In a myositis clinical trial, doctors first assess eligibility through medical evaluation and basic tests. Eligible participants then receive either the study medicine or placebo alongside standard-of-care treatment, with close follow-up over the trial period. Researchers track outcomes such as muscle strength, fatigue, rashes, pain, and day-to-day functioning.

Participation is voluntary, and each study follows strict ethical and safety protocols. When patients choose to participate, they help accelerate better treatments for the entire myositis community.